Participants will be instructed to take two capsules once per day in the morning, thirty minutes before a meal. Clinic staff will instruct participants to save all unused and open packages and return them to clinic at each subsequent visit (visit 3, visit 4 and visit 5) for a determination of compliance. If a dose is missed, participants are instructed to take one as soon as they remember that day. Participants will be advised not to exceed two capsules daily.

Hyperlipidemias

Hypertension

A product made of highly concentrated pharmaceutical grade notoginseng root extract, and containing high potency bioactive components, notoginsenoside, ginsenoside Rb1, Rg1, Rd, Re and Rb2.

Farlong NotoGinseng™ (Farlong Ginseng Plus®)

Turmeric 0.4%, Rice Flour 76.6%, Magnesium stearate 23%, capsule shell (gelatin) 61 mg

Placebo

The Effect of Farlong® NotoGinseng™ (Farlong® Ginseng Plu®) on Cholesterol and Blood Pressure

A Randomized, Placebo-controlled, Double-blind, Parallel Study to Determine the Effect of Farlong® NotoGinseng™ (Farlong® Ginseng Plu®) on Cholesterol and Blood Pressure

The difference in serum LDL-C from baseline to week 12 between Farlong NotoGinseng™ (Farlong Ginseng Plus®) and placebo after 12 weeks of supplementation.

1. The difference in serum LDL-C from baseline to week 8 between Farlong Notoginseng and placebo

2. The difference in blood pressure from baseline to week 8 between Farlong Notoginseng and placebo

3. The difference in blood pressure from baseline to week 12 between Farlong Notoginseng and placebo

4. The difference in triglycerides from baseline to week 8 between Farlong Notoginseng and placebo

5. The difference in triglycerides from baseline to week 12 between Farlong Notoginseng and placebo

6. The difference in HDL-C from baseline to week 8 between Farlong Notoginseng and placebo

7. The difference in HDL-C from baseline to week 12 between Farlong Notoginseng and placebo

8. The difference in total cholesterol from baseline to week 8 between Farlong Notoginseng and placebo

9. The difference in total cholesterol from baseline to week 12 between Farlong Notoginseng and placebo

10. The difference in endothelial vasodilation, as measured by the EndoPAT, from baseline to week 8 between Farlong Notoginseng and placebo

11. The difference in endothelial vasodilation, as measured by the EndoPAT, from baseline to week 12 between Farlong Notoginseng and placebo

LongStar HealthPro, Inc. DBA Farlong Pharmaceutical

Yunnan PanLongYunHai Pharmaceuticals, Ltd.

KGK Science Inc.

This was a randomized, placebo-controlled, double-blind, parallel study with a 4-week therapeutic lifestyle change diet (TLC) run-in period and a 12-week supplementation period.

Hyperparathyroidism, Secondary

For the Regpara those taking 25 mg per day to get the default dose and the dose is adjusted according to the levels of calcium and parathyroid hormone. By adjusting the dose of 25 mg every 3 weeks for a period of 12 weeks, the drug is between 25-75 mg dose, with a maximum dose of not more than 100 mg per day (weeks 3, 6, 9).

calcium sensing receptor agonist

Chulalongkorn Memorial Hospital

The Study of Efficacy and Safety of REGPARA Drug in Dialysis Patients Have High Blood Levels of Parathyroid

The Study of Efficacy and Safety of Calcium Sensing Receptor in Chronic Dialysis Patients

Regpara those taking 25 mg per day to get the default dose and the dose is adjusted according to the levels of calcium and parathyroid hormone. By adjusted dose of 25 mg every 3 weeks (weeks 3, 6, 9) for a period of 12 weeks, the drug is between 25-75 mg dose, with a maximum dose of not more than 100 mg per day .

The Regpara those taking 25 mg per day to get the default dose and the dose is adjusted according to the levels of calcium and parathyroid hormone. By adjusted dose of 25 mg every 3 weeks (weeks 3, 6, 9) for a period of 12 weeks, the drug is between 25-75 mg dose, with a maximum dose of not more than 100 mg per day .

Chulalongkorn University

Patients on atorvastatin treatment hospitalised due to cardiovascular events

Cardiovascular Disorders

Patients on atorvastatin treatment

Rio University Hospital

Euroclinic Private Hospital

Evagelismos General State Hospital

Gennimatas General State Hospital

Konstantopoulio General Hospital

General State Hospital

University Hospital

Hippokration General Hospital

Sismanogleio General State Hospital

Tzannion General State Hospital

424 Military Hospital

Papageorgiou Hospital

Ekvasis of Atorvastatin (Antorcin®) Treatment in Patients With Acute Cardiovascular Events

A Multicenter, Open-label, 30-week Observational Clinical Study to Examine the Progress of Patients After Leaving the Cardiology Clinic or Unit Due to Acute Cardiovascular Event.

The evaluation of atorvastatin treatment to all patients with cardiovascular events and separate the two subgroups (diabetes type II patients with metabolic syndrome) in order to achieve the level of lipids (LDL-C, HDL-C, T-CHOL) plasma blood

Achieving the level of lipids (LDL-C, HDL-C, T-CHOL) in blood plasma of patients in the atorvastatin dosage: those who received the 40 mg dose and those who received a dose of 80 mg

The investigation of compliance to treatment (days without taking medication, changing the time of intake) and its correlation with the achievement of target lipid levels (LDL-C, HDL-C, T-CHOL) in blood plasma of the studied patients

Safety evaluation by adverse events reporting

The reporting of hematological and biochemical tests where conducted at each hospital center, as part of their standard clinical practice

The determination of dyslipidemia class it belongs to each patient in order to assess the efficacy of atorvastatin administered.

Elpen Pharmaceutical Co. Inc.

This arm will consume 90 grams of beans per day for 5 out of 7 days for 6 weeks.

The control group will consume 90 grams of rice per day for 5 out of 7 days for 6 weeks.

This arm will consume 90g of peas per day for 5 days out of each week for 6 weeks.

Hypercholesterolemia

90g of beans per day for 5 out of 7 days per week will be given to participants for 6 weeks to determine the cholesterol lowering effects of various pulses.

Beans

90g of rice per day will be given to the control group to demonstrate the cholesterol lowering effects of the experimental group.

Control (rice)

90 grams of peas will be consumed 5 out of 7 days per week

sterol/stroke

The Effect of Farlong® NotoGinseng™ (Farlong® Ginseng Plu®) on Cholesterol and Blood Pressure

The Study of Efficacy and Safety of REGPARA Drug in Dialysis Patients Have High Blood Levels of Parathyroid

Ekvasis of Atorvastatin (Antorcin®) Treatment in Patients With Acute Cardiovascular Events

U of A/ U of M Beans and Peas Health Claim Project

Baz done ki pi konplè remèd fèy medsin te apiye nan syans